Identification of a Primary Target of Thalidomide Teratogenicity

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Science

• Publication date

  2010-03-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/science.1177319PMID 20223979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer

  2010cited by this paper
• Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

  2009cited by this paper
• Development and application of high-performance affinity beads: toward chemical biology and drug discovery.

  2009cited by this paper
• Shedding light on an old mystery: Thalidomide suppresses survival pathways to induce limb defects

  2008cited by this paper
• Zebrafish as a Developmental Model Organism for Pediatric Research

  2008cited by this paper
• An autopodial-like pattern of Hox expression in the fins of a basal actinopterygian fish

  2007cited by this paper
• BMP signals control limb bud interdigital programmed cell death by regulating FGF signaling

  2007cited by this paper
• Thalidomide induces limb deformities by perturbing the Bmp/Dkkl/Wnt signaling pathway

  2007cited by this paper
• The thalidomide saga.

  2007cited by this paper
• Dioxin receptor is a ligand-dependent E3 ubiquitin ligase

  2007cited by this paper
• DDB1 is essential for genomic stability in developing epidermis

  2007cited by this paper
• Neurology®

  2007cited by this paper
• Deletion of DDB1 in mouse brain and lens leads to p53-dependent elimination of proliferating cells.

  2006cited by this paper
• A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

  2006cited by this paper
• Molecular architecture and assembly of the DDB1–CUL4A ubiquitin ligase machinery

  2006cited by this paper
• Function and regulation of cullin–RING ubiquitin ligases

  2005cited by this paper
• UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex.

  2005cited by this paper
• Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate.

  2005cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Thalidomide Pharmacokinetics and Metabolite Formation in Mice, Rabbits, and Multiple Myeloma Patients

  2004cited by this paper
• A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation

  2004cited by this paper
• J.Chromatogr., B: Anal. Technol. Biomed. Life Sci.

  2004cited by this paper
• The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage.

  2003cited by this paper
• Misregulation of gene expression in the redox‐sensitive NF‐κb‐dependent limb outgrowth pathway by thalidomide

  2002cited by this paper
• Fin development in a cartilaginous fish and the origin of vertebrate limbs

  2002cited by this paper
• Origin of the vertebrate inner ear: evolution and induction of the otic placode

  2001cited by this paper
• Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

  2001cited by this paper
• Fgf8 is required for outgrowth and patterning of the limbs

  2000cited by this paper
• Fgf8 signalling from the AER is essential for normal limb development

  2000cited by this paper
• Effective targeted gene ‘knockdown’ in zebrafish

  2000cited by this paper
• Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.

  1999cited by this paper
• S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide.

  1999cited by this paper
• Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity

  1999cited by this paper
• Antitumor activity of thalidomide in refractory multiple myeloma.

  1999cited by this paper
• Development

  1996cited by this paper
• Thalidomide is an inhibitor of angiogenesis.

  1994cited by this paper
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

  1993cited by this paper
• Sonic hedgehog mediates the polarizing activity of the ZPA.

  1993cited by this paper
• Blood.

  1989cited by this paper
• Teratology.

  1986cited by this paper
• Thalidomide in the treatment of lepra reactions

  1965cited by this paper

• Developmental and reproductive toxicity assessment of sporoderm-removed Ganoderma lucidum spores

  2026cites this paper
• Evaluation of protein degradation by new proteolysis targeting chimera in human cervical adenocarcinoma epithelial cells and an in vivo mouse model

  2026cites this paper
• Unlocking the potential of computational phenotypic drug discovery: methods, challenges, and future directions.

  2026cites this paper
• ProxiCapture Reveals Context-Dependent CRBN Interactome Landscape of Molecular Glue Degraders

  2026cites this paper
• Bridged PROTAC, DNA-based PROTAC and hydrophobic tag technologies for targeted protein degradation.

  2026cites this paper
• Advances in BRET probes for intracellular target engagement studies.

  2026cites this paper
• Targeted degradation of BRD4 by PROTACs: advances in cancer therapy.

  2026cites this paper
• Structure-Activity Relationships of Designed α-Amino Hydroxamic Acids for Affinity Labeling via In Situ Isocyanate Generation.

  2026cites this paper
• Covalent chemistry in targeted protein degradation.

  2026cites this paper
• Dual targeting of AMRC12 and Malassezia globosa disrupts MYC liquid condensates-driven nuclear pore complex biogenesis in neuroblastoma

  2026cites this paper
• Dual Target E3 Ligase Ligands: A New Way to Overcome Drug Resistance

  2026cites this paper
• Selenoprotein thioredoxin reductase 1 promotes cancer cells ferroptosis by suppressing GPX4 expression.

  2026cites this paper
• Artifact-Free Dark-Field Scattering Microspectroscopy for Single-Particle Chiral Measurements at the Nanoscale.

  2026cites this paper
• Neo-Cysteine Molecular Glues for Targeting Mutated SMAD4 Protein.

  2026cites this paper
• Reinforced molecular dynamics: Physics-infused generative machine learning model simulates protein motion

  2026cites this paper
• A Novel Paradigm for Targeting Challenging Targets: Advancing Technologies and Future Directions of Molecular Glue Degraders

  2026cites this paper
• Insights into Racemization of Metal Nanoclusters and Strategic Spontaneous Resolution.

  2026cites this paper
• Accelerated synthesis of immunomodulatory imide drugs and their derivatives via continuous flow chemistry.

  2026cites this paper
• Patent alert for targeted protein degradation

  2026cites this paper
• Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicry.

  2026cites this paper
• Quantitative Degradation Rate Assessment of bioPROTACs Based on Peptide Degrons, E3 Domains, Adapters and Conjugated Small Molecules

  2026cites this paper
• Endothelial KSR2 regulated by genetic variation protects against atherosclerosis through AMPKα1 stabilization

  2026cites this paper
• Identification of an allosteric site on the E3 ligase adapter cereblon.

  2026cites this paper
• Synergistic targeting of the ARID2–MYC axis by pomalidomide and panobinostat overcomes intrinsic IMiD resistance in multiple myeloma

  2026cites this paper
• High-throughput ligand diversification to discover chemical inducers of proximity.

  2026cites this paper
• Molecular glue degraders: Rational design, specificity engineering, and advanced delivery

  2026cites this paper
• Semi-rigid linkers improve the pharmacokinetic properties and therapeutic efficacy of BET PROTACs for cancer therapy.

  2026cites this paper
• Thiostrepton Suppresses the Progression of Rhabdomyosarcoma by Inhibiting the PI3K‐AKT Signaling Pathway

  2025cites this paper
• Advances in DNA-based proteolysis-targeting chimeras technology: Novel strategies for targeting previously undruggable proteins in cancer therapy.

  2025cites this paper
• Dynamic ubiquitination networks in liver cancer: decoding E3 ligases and deubiquitinases as gatekeepers of therapeutic resistance

  2025cites this paper
• Targeted Protein Degradation and Protein-condensate Degradation for Plant Science and Crop Breeding.

  2025cites this paper
• Single-Cell Sequencing Reveals Thalidomide-Induced Teratogenicity in Zebrafish via Endoplasmic Reticulum Stress and Dysregulated Angiogenic Signaling.

  2025cites this paper
• Design and Application of Cereblon-Recruiting Prodegraders.

  2025cites this paper
• Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs

  2025cites this paper
• In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation.

  2025cites this paper
• The contribution of cyclic imide stereoisomers on cereblon-dependent activity

  2025cites this paper
• Beyond the G-Loop: CRBN Molecular Glues Potently Target VAV1 via a Novel SH3 RT-Loop Degron

  2025cites this paper
• Ubiquitin-conjugating enzyme UBE2N modulates proteostasis in immunoproteasome-positive acute myeloid leukemia

  2025cites this paper
• Niclosamide: CRL4AMBRA1 mediated degradation of cyclin D1 following mitochondrial membrane depolarization

  2025cites this paper
• New insight into teratogenic effects of (S)-thalidomide in zebrafish embryos growing inside the chorion and subjected to electric pulses

  2025cites this paper
• Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration

  2025cites this paper
• Hydrogen‐Deuterium Exchange Mass Spectrometry for Molecular Glue Characterization

  2025cites this paper
• Isoindolinone Derivatives: Synthesis, In Vitro Anticancer, Antioxidant, and Molecular Docking Studies

  2025cites this paper
• Rare biochemical & genetic conditions: clues for broader mechanistic insights

  2025cites this paper
• Synthesis and Characterization of Iron Oxide-Thalidomide Nanoconjugates for Enhanced Anti-Inflammatory Activities

  2025cites this paper
• Identification of E3 Ubiquitin Ligase Substrates Using Biotin Ligase-Based Proximity Labeling Approaches

  2025cites this paper
• Cellular parameters shaping pathways of targeted protein degradation

  2025cites this paper
• Quantifying Cooperativity through Binding Free Energies in Molecular Glue Degraders

  2025cites this paper
• Unveiling New Triazoloquinoxaline‐Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9

  2025cites this paper
• Discovery of an LSD1 PROTAC degrader

  2025influential citation
• Protein turnover downstream of the Nipbl/CRL4 axis contributes to abnormal development in zebrafish embryos.

  2025cites this paper
• Guidance on the interpretation of CRBN mutations in myeloma.

  2025cites this paper
• Functionalized Cellulose Derivatives: Challenge or Opportunity in the Field of Chiral and Achiral Sensing.

  2025cites this paper
• The design and synthesis of a novel α-alkynylated biotin scaffold for use in heterobifunctional molecular probes

  2025cites this paper
• Investigation of Glutarimide N-Alkylated Derivatives of Lenalidomide.

  2025cites this paper
• Adsorption ability of graphitic carbon nitride C6N6 toward temozolomide and thalidomide drugs: a DFT study

  2025cites this paper
• High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader

  2025cites this paper
• Stick it with VHL

  2025cites this paper
• Cardiovascular manifestations of thalidomide embryopathy.

  2025cites this paper
• Serum Cereblon (CRBN) Levels Predict Long Term Post- Lenalidomide-Dexamethasone Survival in Multiple Myeloma (MM) Patients and Correlate with Disease Characteristics

  2025influential citation
• Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognition.

  2025cites this paper
• Unveiling the hidden interactome of CRBN molecular glues

  2025cites this paper
• Catalytic Castagnoli--Cushman reaction-based synthesis of tetrahydroisoquinolone--glutarimide dyads and their evaluation as potential cereblon ligands

  2025cites this paper
• Self-assembled PROTACs enable glycoproteins degradation in the living cells

  2025cites this paper
• Proteolysis targeting chimera, molecular glue degrader and hydrophobic tag tethering degrader for targeted protein degradation: Mechanisms, strategies and application.

  2025cites this paper
• A method for the detection and enrichment of endogenous cereblon substrates

  2025cites this paper
• PCMT1 generates the C-terminal cyclic imide degron on CRBN substrates

  2025cites this paper
• Targeted degradation of CDK9 potently disrupts the MYC-regulated network.

  2025cites this paper
• Can we develop effective direct or indirect inhibitors of transcription factors? On the clinical evolution of protein degraders for multiple myeloma therapy

  2025cites this paper
• Molecular glues that inhibit deubiquitylase activity and inflammatory signaling

  2025cites this paper
• The Supportive Role of Lymph Node Mesenchymal Stromal Cells in Follicular Lymphoma Involves the PITX1–hTERT–Podoplanin Axis

  2025cites this paper
• Cereblon E3 Ligase Complex genes are expressed in tissues sensitive to thalidomide in chicken and zebrafish embryos but are unchanged following thalidomide exposure.

  2025cites this paper
• Recent advances in the chemistry and biology of plant oxylipin hormones.

  2025cites this paper
• Research Progress of IMiDs as PPI Stabilizer in Protein Degradation

  2025cites this paper
• Ubiquitin-proteasome system: a potential participant and therapeutic target in antiphospholipid syndrome

  2025cites this paper
• Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy synergy between CARM1 inhibition and IMiDs

  2025cites this paper
• Influence of Cytokine-Related genetic variants in TNF, IL6, IL1β, and IFNγ genes in the thalidomide treatment for Erythema nodosum leprosum in a Brazilian population sample.

  2025cites this paper
• A Chiral Sensing System Based on Single Au Nanowire: A General SERS Strategy for Identification of the Enantiomers and Mechanism for Chiral Interaction.

  2025cites this paper
• Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome

  2025cites this paper
• Effect of metachronous primary and secondary solid cancers in patients with multiple myeloma: a retrospective study from a single-center

  2025cites this paper
• 3-Monothiopomalidomide, a new immunomodulatory imide drug (IMiD), blunts inflammation and mitigates ischemic stroke in the rat

  2025cites this paper
• CUL4A exhibits tumor-suppressing role via regulation of HUWE1-mediated SMAD3 intracellular shuttling.

  2025cites this paper
• Advancements in Proteolysis Targeting Chimeras for Targeted Therapeutic Strategies in Alzheimer’s Disease

  2025cites this paper
• High-throughput protein target mapping enables accelerated bioactivity discovery for ToxCast and PFAS compounds

  2025cites this paper
• How Temperature Change Affects the Lattice Parameters, Molecular Conformation, and Reaction Cavity in Enantiomeric and Racemic Crystals of Thalidomide.

  2025cites this paper
• Native mass spectrometry for proximity-inducing compounds: a new opportunity for studying chemical-induced protein modulation

  2025cites this paper
• Probing the E3 Ligase Adapter Cereblon with Chemical Biology.

  2025cites this paper
• Protein covariation networks for elucidating ferroptosis inducer mechanisms and potential synergistic drug targets

  2025influential citation
• A method to identify small molecule/protein pairs susceptible to protein ubiquitination by the CRBN E3 ligase

  2025cites this paper
• Probing attosecond dynamics of chiral bound wave packets with an attoclock

  2025cites this paper
• Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation

  2025cites this paper
• Thalidomide-induced limb malformations: an update and reevaluation

  2025cites this paper
• A novel cereblon variant with both exon 8 and 10 deletions in newly diagnosed and relapsed multiple myeloma

  2025cites this paper
• The Latest Advancements of the PROTACs Based on CRBN E3 Ligase for Cancer Treatment

  2025cites this paper
• Exome Sequencing to Identify Novel Susceptibility Genes for Nonsyndromic Split‐Hand/Ft Malformation: A Report From the National Birth Defects Prevention Study

  2025cites this paper
• Targeting the Exonic Circular OGT RNA/O-GlcNAc Transferase/Forkhead Box C1 Axis Inhibits Asparagine- and Alanine-Mediated Ferroptosis Repression in Neuroblastoma Progression

  2025cites this paper
• In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID

  2025cites this paper
• Discovery of Artesunate (ARS) PROTACs as GPX4 protein degraders for the treatment of bladder cancer.

  2025cites this paper
• Proteolysis‐Targeting Chimera (PROTAC): A Revolutionary Tool for Chemical Biology Research

  2025cites this paper
• Reinforced molecular dynamics: Physics-infused generative machine learning model explores CRBN activation process

  2025cites this paper